Publications

5891 Results

Letter to the Editor: RE: RE: Chemoprevention of urological cancer

Authors
IM Thompson;CA Coltman
Journal / Conference
Journal of Urology 164(4):1321-1322
Year
2000
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Colon cancer survival is associated iwth increasing number of lymph nodes removed. a secondary analysis of INT-0089

Authors
TE Lo Voyer;ER Sigurdson;AL Hanlon;RJ Mayer;JS Macdonald;PJ Catalano;DG Haller
Journal / Conference
Proc of the American Society of Clinical Oncology 19:239a(#925)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

Phase III study comparing three cycles of infusional BCNU/Cisplatin followed by radiation with radiation and concurrent BCNU for patients with newly diagnosed supratentorial glioblastoma multiforme (ECOG 2394 - SWOG 9508)

Authors
SA Grossman;A O'Neill;M Grunnet;M Mehta;J Pearlman;H Wagner;M Gilbert;H Newton;R Hellman
Journal / Conference
Proc of the American Society of Clinical Oncology 19:158a(#612)
Year
2000
Research Committee(s)
Brain
Study Number(s)
SWOG-9508

Phase II evaluation of interleukin-4 in patients with non-hodgkin's lymphoma: a Southwest Oncology Group trial

Authors
CW Taylor;M LeBlanc;RI Fisher;DF Moore, Sr;RW Roach;L Elias;TP Miller
Journal / Conference
Anti-Cancer Drugs 11:695-700
Year
2000
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9219

Minority recruitment in the prostate cancer prevention trial

Authors
CM Moinpour;JO Atkinson;SM Thomas;S Millon-Underwood;C Harvey;J Parzuchowski;LC Lovato;AM Ryan;S Hill;E DeAntoni;ER Gritz;IM Thompson, Jr;CA Coltman, Jr
Journal / Conference
Annals of Epidemiology 10(S8):S85-S91
Year
2000
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Increased incidence of mutations in the granulocyte-colony stimulating factor receptor in patients with acute myeloid leukemia and chromosome 7 abnormalities without antecedent severe congenital neutropenia.

Authors
LJ Druhan;AC Lidral;CL Willman;ML Slovak;KJ Kopecky;BR Avalos
Journal / Conference
Blood 96(11):83a(#354)
Year
2000
Research Committee(s)
Leukemia

A phase III randomized intergroup trial of subtotal lymphoid irradiation (STLI) versus doxorubicin, vinblastine, and STLI for stage IA-IIA Hodgkin's disease (SWOG 9133, CALGB 9391)

Authors
OW Press;M LeBlanc;A Lichter;TH Wassermann;T Miller;R Fisher
Journal / Conference
Blood 96(11):575a(#2471)
Year
2000
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9133

Phase III trials in patients with advanced stage non-small cell lung cancer (NSCLC) from 1973-1994

Authors
BE Johnson;B Freidlin;B Conley;MR Green;DJ Johnson;DR Gandara;MJ O'Connel;R Simon;OS Breathnach
Journal / Conference
Proc of the American Society of Clinical Oncology 19:488a(#1909)
Year
2000
Research Committee(s)
Lung

Predictive value of automated, quantitative real-time RT-PCR performed at the end of consolidation of acute promyelocytic leukemia (APL): a SWOG, CALGB, and ECOG Intergroup study (INT-0129)

Authors
CL Willman;B Yeap;W Bi;JC Slack;DP Harrington;KJ Livak;FR Appelbaum;CD Bloomfield;MS Tallman;RE Gallagher
Journal / Conference
Proc of the American Society of Clinical Oncology 19:5a(#9)
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Thioredoxin, a putative oncogene product is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival

Authors
TM Grogan;C Fenoglio-Prieser;R Zeheb;W Bellamy;Y Frutiger;E Vela;G Stemmerman;J Macdonald;L Richter;A Gallegos;G Powis
Journal / Conference
Human Pathology 31(4):475-481
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)